Postoperative analgesia for total knee replacement: a comparison between intrathecal morphine and peripheral nerve blocks
ISRCTN | ISRCTN53794597 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN53794597 |
Secondary identifying numbers | 1. |
- Submission date
- 18/10/2006
- Registration date
- 07/11/2006
- Last edited
- 07/03/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Maruthi S R R Ganugapenta
Scientific
Scientific
50,Milestone Close
Heath
Cardiff
CF14 4NQ
United Kingdom
Phone | +44 (0) 2920691036 |
---|---|
reddymaruthi@yahoo.com |
Study information
Study design | Double blind randomised controlled study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | Postoperative analgesia for total knee replacement: a comparison between IntraThecal Morphine and Peripheral Nerve Blocks |
Study acronym | ITM vs PNB |
Study objectives | The aim of this study is to compare intrathecal morphine with peripheral nerve block for postoperative analgesia following unilateral primary total knee replacement. |
Ethics approval(s) | South East Wales Research Ethics Committee, February 2007, ref: 06/WSE04/126 |
Health condition(s) or problem(s) studied | Analgesia following total knee replacements |
Intervention | Spinal Anaesthesia: A fine needle in the lower back. We will give 3 ml of 0.5% heavy Bupivacaine in one group and the same volume in the second group but combined with morphine 7 micrograms/Kg, maximum of 500 microgram. Femoral 3 in 1 block: In the groin 30 ml of plain Bupivacaine 0.38% will be injected close to the Femoral nerve with a special locator needle. This is done in group one. Sciatic nerve block: In the buttock 15 ml of 0.38% plain Bupivacaine will be injected close to the Sciatic nerve with the special locator needle.This is also done in group one. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Intrathecal morphine, Tramadol |
Primary outcome measure | Quality of pain relief on movement of knee joint. |
Secondary outcome measures | The secondary outcome measures include: 1. The number of patients requiring rescue analgesia 2. Time for the first dose of Tramadol 3. The incidence of the adverse effects of Morphine and Visual Analogue Scale (VAS) for patient satisfaction at 48 hours |
Overall study start date | 01/01/2007 |
Completion date | 31/12/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 80 |
Key inclusion criteria | 1. Primary elective total knee replacement 2. Fit patients of American Society of Anesthesiologists (ASA) classification one to three |
Key exclusion criteria | 1. Patients who refuse consent 2. Revision surgery 3. Had adverse reaction or a contraindication to the administration of morphine, local anaesthetics, non-steroidal anti-inflammatory drugs, paracetamol, tramadol, centrineuraxial block and peripheral nerve blocks 4. Patient with history of chronic pain other than at the site of joint replacement 5. Used regular strong opioids 6. Renal impairment 7. Liver impairment 8. ASA physical status greater than three |
Date of first enrolment | 01/01/2007 |
Date of final enrolment | 31/12/2007 |
Locations
Countries of recruitment
- United Kingdom
- Wales
Study participating centre
50,Milestone Close
Cardiff
CF14 4NQ
United Kingdom
CF14 4NQ
United Kingdom
Sponsor information
Gwent Healthcare NHS Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
c/o Ms Rosamund Howell
Postgraduate Centre
The Friars
Friars Road
Newport
NP20 4EZ
Wales
United Kingdom
Phone | +44 (0)1633 238138 |
---|---|
Rosamund.howell@gwent.wales.nhs.uk | |
Website | http://www.wales.nhs.uk/sites3/home.cfm?OrgID=79 |
https://ror.org/045gxp391 |
Funders
Funder type
Government
Royal Gwent Hospital Trust Research and Development (Reg: RD/505/06) - No external funding is necessary
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
07/03/2017: No publications found in PubMed, verifying study status with principal investigator